First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009

Ross A. Soo, Benjamin O. Anderson, Byoung Chul Cho, Chih Hsin Yang, Meilin Liao, Wan Teck Lim, Peter Goldstraw, Tony S. Mok

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations.

Original languageEnglish
Pages (from-to)1102-1110
Number of pages9
JournalThe Lancet Oncology
Volume10
Issue number11
DOIs
Publication statusPublished - 2009 Nov

Fingerprint

Non-Small Cell Lung Carcinoma
Guidelines
Health Services Accessibility
Tobacco
Organizations
Delivery of Health Care
Education
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Soo, Ross A. ; Anderson, Benjamin O. ; Cho, Byoung Chul ; Yang, Chih Hsin ; Liao, Meilin ; Lim, Wan Teck ; Goldstraw, Peter ; Mok, Tony S. / First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia : consensus statement from the Asian Oncology Summit 2009. In: The Lancet Oncology. 2009 ; Vol. 10, No. 11. pp. 1102-1110.
@article{c1934114d9c248cea119bd857bfdc60b,
title = "First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009",
abstract = "Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations.",
author = "Soo, {Ross A.} and Anderson, {Benjamin O.} and Cho, {Byoung Chul} and Yang, {Chih Hsin} and Meilin Liao and Lim, {Wan Teck} and Peter Goldstraw and Mok, {Tony S.}",
year = "2009",
month = "11",
doi = "10.1016/S1470-2045(09)70238-4",
language = "English",
volume = "10",
pages = "1102--1110",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "11",

}

First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia : consensus statement from the Asian Oncology Summit 2009. / Soo, Ross A.; Anderson, Benjamin O.; Cho, Byoung Chul; Yang, Chih Hsin; Liao, Meilin; Lim, Wan Teck; Goldstraw, Peter; Mok, Tony S.

In: The Lancet Oncology, Vol. 10, No. 11, 11.2009, p. 1102-1110.

Research output: Contribution to journalReview article

TY - JOUR

T1 - First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia

T2 - consensus statement from the Asian Oncology Summit 2009

AU - Soo, Ross A.

AU - Anderson, Benjamin O.

AU - Cho, Byoung Chul

AU - Yang, Chih Hsin

AU - Liao, Meilin

AU - Lim, Wan Teck

AU - Goldstraw, Peter

AU - Mok, Tony S.

PY - 2009/11

Y1 - 2009/11

N2 - Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations.

AB - Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations.

UR - http://www.scopus.com/inward/record.url?scp=71549117595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71549117595&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(09)70238-4

DO - 10.1016/S1470-2045(09)70238-4

M3 - Review article

C2 - 19880064

AN - SCOPUS:71549117595

VL - 10

SP - 1102

EP - 1110

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 11

ER -